Device Trial Radar · NCT05888194
The Effect of Mucogyne® Gel on Wound Healing
Last checked: Nov 20, 2026Latest source record: Mar 12, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
118
Planned (sponsor's estimate)
Start
Jun 12, 2023
Primary completion
May 2024
Study completion May 2024
Sponsor
- Lead sponsor
- BiocodexNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 5, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this post-market clinical follow up study is to confirm the efficacy and safety of topical application of Mucogyne® gel in the process of wound healing, when used in accordance with its approved labeling, in the context of postpartum perineal wounds.
Conditions
- Perineal Tear and Episiotomy
Interventions
Mucogyne® gelDevice
In Mucogyne group, each eligible patient will receive a box of Mucogyne® gel. The patient will apply Mucogyne® gel, 48-hours after delivery, everyday, twice a day, massaging it into the intimate area, for a 10-day period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- To assess the effectiveness of topical application of Mucogyne® gel in postpartum perineal wound healing promotion.Time frame: Day 0 to Day 12 (+/-2) after delivery
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
CHU Lille
Lille, France · Recruiting
CHU Montpellier
Montpellier, France · Recruiting
CHU Strasbourg
Strasbourg, France · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.